National Corporation for Tourism and Hotels (ADX:NCTH)
United Arab Emirates · Delayed Price · Currency is AED 2.050
-0.030 (-1.44%)
At close: Aug 1, 2025, 2:44 PM GST
Sage Therapeutics Income Statement
Financials in millions AED. Fiscal year is January - December.
Millions AED. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 1,273 | 698.56 | 669.2 | 710.6 | 759.36 | 765.44 | Upgrade | |
Revenue Growth (YoY) | 53.95% | 4.39% | -5.83% | -6.42% | -0.79% | -0.27% | Upgrade |
Cost of Revenue | 968.73 | 598.71 | 572.59 | 625.35 | 655.64 | 663.9 | Upgrade |
Gross Profit | 303.88 | 99.84 | 96.62 | 85.25 | 103.72 | 101.54 | Upgrade |
Selling, General & Admin | 160.37 | 15.59 | 16.23 | 15.48 | 18.95 | 18.1 | Upgrade |
Other Operating Expenses | -19.85 | 1.48 | 4.7 | 0.46 | 12.6 | 7.24 | Upgrade |
Operating Expenses | 140.95 | 17.92 | 21.73 | 17.57 | 33.94 | 27.73 | Upgrade |
Operating Income | 162.93 | 81.92 | 74.89 | 67.68 | 69.78 | 73.81 | Upgrade |
Interest Expense | -33.6 | -29.57 | -19.97 | -7.16 | -7.58 | -8.18 | Upgrade |
Interest & Investment Income | 12.64 | 16.57 | 14.28 | 9.04 | 18.5 | 17.6 | Upgrade |
Earnings From Equity Investments | 7.38 | 12.59 | 4.77 | -2.51 | 1.82 | 1.79 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | - | - | -4 | Upgrade |
EBT Excluding Unusual Items | 149.35 | 81.51 | 73.97 | 67.04 | 82.53 | 81.02 | Upgrade |
Gain (Loss) on Sale of Investments | 3.95 | -1.81 | -6.81 | -4.62 | 1.55 | 17.66 | Upgrade |
Gain (Loss) on Sale of Assets | 0.16 | 0.16 | 0.84 | 0.65 | 17.42 | 0.33 | Upgrade |
Asset Writedown | 0.12 | 0.12 | 0.08 | 0.9 | - | - | Upgrade |
Other Unusual Items | 178.53 | - | - | - | - | 15.77 | Upgrade |
Pretax Income | 332.1 | 79.98 | 68.08 | 63.98 | 101.49 | 114.78 | Upgrade |
Income Tax Expense | 22.64 | 5.95 | - | - | - | - | Upgrade |
Net Income | 309.47 | 74.03 | 68.08 | 63.98 | 101.49 | 114.78 | Upgrade |
Net Income to Common | 309.47 | 74.03 | 68.08 | 63.98 | 101.49 | 114.78 | Upgrade |
Net Income Growth | 165.85% | 8.74% | 6.42% | -36.96% | -11.58% | 3.76% | Upgrade |
Shares Outstanding (Basic) | 1,420 | 899 | 899 | 899 | 899 | 899 | Upgrade |
Shares Outstanding (Diluted) | 1,420 | 899 | 899 | 899 | 899 | 899 | Upgrade |
EPS (Basic) | 0.22 | 0.08 | 0.08 | 0.07 | 0.11 | 0.13 | Upgrade |
EPS (Diluted) | 0.22 | 0.08 | 0.08 | 0.07 | 0.11 | 0.13 | Upgrade |
EPS Growth | 86.02% | 8.74% | 6.42% | -36.96% | -11.58% | 3.75% | Upgrade |
Free Cash Flow | 103.86 | 118.97 | 11.17 | -15.18 | -32.51 | -5.92 | Upgrade |
Free Cash Flow Per Share | 0.07 | 0.13 | 0.01 | -0.02 | -0.04 | -0.01 | Upgrade |
Dividend Per Share | - | - | - | - | 0.114 | 0.114 | Upgrade |
Dividend Growth | - | - | - | - | 0.09% | 29.98% | Upgrade |
Gross Margin | 23.88% | 14.29% | 14.44% | 12.00% | 13.66% | 13.27% | Upgrade |
Operating Margin | 12.80% | 11.73% | 11.19% | 9.53% | 9.19% | 9.64% | Upgrade |
Profit Margin | 24.32% | 10.60% | 10.17% | 9.00% | 13.36% | 14.99% | Upgrade |
Free Cash Flow Margin | 8.16% | 17.03% | 1.67% | -2.14% | -4.28% | -0.77% | Upgrade |
EBITDA | 256.67 | 120.32 | 103.02 | 97.29 | 108.86 | 110.62 | Upgrade |
EBITDA Margin | 20.17% | 17.22% | 15.39% | 13.69% | 14.34% | 14.45% | Upgrade |
D&A For EBITDA | 93.74 | 38.4 | 28.13 | 29.61 | 39.07 | 36.81 | Upgrade |
EBIT | 162.93 | 81.92 | 74.89 | 67.68 | 69.78 | 73.81 | Upgrade |
EBIT Margin | 12.80% | 11.73% | 11.19% | 9.53% | 9.19% | 9.64% | Upgrade |
Effective Tax Rate | 6.82% | 7.43% | - | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.